Genmab A/S Stock Forward View - Price Action Indicator
| GE9 Stock | EUR 274.90 0.50 0.18% |
Genmab Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Genmab A/S's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 2nd of February 2026, The relative strength index (RSI) of Genmab A/S's share price is at 51. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Genmab A/S, making its price go up or down. Momentum 51
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 1.076 | Wall Street Target Price 480.81 | EPS Estimate Current Quarter 1.31 | Quarterly Revenue Growth 0.174 |
Using Genmab A/S hype-based prediction, you can estimate the value of Genmab AS from the perspective of Genmab A/S response to recently generated media hype and the effects of current headlines on its competitors.
Genmab A/S after-hype prediction price | EUR 272.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Genmab |
Genmab A/S Additional Predictive Modules
Most predictive techniques to examine Genmab price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genmab using various technical indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Genmab A/S Volatility | Backtest Genmab A/S | Information Ratio |
Genmab A/S Trading Date Momentum
| On February 02 2026 Genmab AS was traded for 274.90 at the closing time. The highest daily price throughout the period was 274.90 and the lowest price was 274.90 . There was no trading activity during the period 0.0. Lack of trading volume on 02/02/2026 did not cause price change. The overall trading delta to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Genmab A/S to competition |
Other Forecasting Options for Genmab A/S
For every potential investor in Genmab, whether a beginner or expert, Genmab A/S's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Genmab Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Genmab. Basic forecasting techniques help filter out the noise by identifying Genmab A/S's price trends.Genmab A/S Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genmab A/S stock to make a market-neutral strategy. Peer analysis of Genmab A/S could also be used in its relative valuation, which is a method of valuing Genmab A/S by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Genmab A/S Market Strength Events
Market strength indicators help investors to evaluate how Genmab A/S stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab A/S shares will generate the highest return on investment. By undertsting and applying Genmab A/S stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 274.9 | |||
| Day Typical Price | 274.9 | |||
| Price Action Indicator | (0.25) | |||
| Period Momentum Indicator | (0.50) | |||
| Relative Strength Index | 51.39 |
Genmab A/S Risk Indicators
The analysis of Genmab A/S's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Genmab A/S's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genmab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.52 | |||
| Semi Deviation | 1.77 | |||
| Standard Deviation | 2.05 | |||
| Variance | 4.2 | |||
| Downside Variance | 4.39 | |||
| Semi Variance | 3.13 | |||
| Expected Short fall | (1.55) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Genmab A/S
The number of cover stories for Genmab A/S depends on current market conditions and Genmab A/S's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Genmab A/S is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Genmab A/S's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Historical Fundamental Analysis of Genmab A/S to cross-verify your projections. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.